glp 1 and antipsychotics Antipsychotic Weight Gain Metabolic Syndrome (MetS) Treatment of Antipsychotic-Induced Weight Gain

While both medications are highly effective, tirzepatide acts on two hormone pathwaysGLP-1 and GIPallowing it to regulate appetite while also improving insulin sensitivity and fat metabolism

Both are legal, but neither produces FDA-approved finished products

Speak to your healthcare provider if: Weight concerns are significantly affecting your mood or self-esteem You are considering stopping fluoxetine due to weight changes You notice signs of disordered eating patterns Weight issues are interfering with your recovery from depression, anxiety, or bulimia Your GP can help balance the benefits of fluoxetine for your mental health against any weight-related concerns, potentially adjusting treatment or providing additional support

But they come with a cost

10.1056/NEJMra1510062 62 WoottenD.ChristopoulosA.Marti-SolanoM.BabuM